The Royal Women's Hospital, located in the Melbourne suburb of Parkville, is Australia's oldest specialist women's hospital. It offers a full range of services in maternity, gynaecology, neonatal care, women's cancers and women's health.

There are 200 beds in Royal Women's Hospital.

During the past decade, Royal Women's Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Women's Hospital" #1 sponsor was "McMaster University" with 3 trials, followed by "AstraZeneca" with 2 trials sponsored, "Ethicon, Inc." with 2 trials sponsored, "University of Melbourne" with 2 trials sponsored and "University of Sydney" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Women's Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "National Health and Medical Research Council, Australia" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator and "Auckland City Hospital" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Royal Women's Hospital" are "Ovarian Cancer" (3 trials), "Apnea of Prematurity" (2 trials), "Bronchopulmonary Dysplasia" (2 trials), "Pelvic Organ Prolapse" (2 trials) and "Adnexal Mass" (1 trials). Many other conditions were trialed in "Royal Women's Hospital" in a lesser frequency.

Most popular intervention types in "Royal Women's Hospital" are "Drug" (13 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Caffeine citrate injection" (2 trials), "Olaparib 300mg tablets" (2 trials), "0.9% Saline" (1 trials) and "Continuation on CPAP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Women's Hospital" are 14 trials for "Female" genders and 9 trials for "All" genders.

Currently, there are NaN active trials in "Royal Women's Hospital". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Royal Women's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Women's Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".